Viewing Study NCT01111903


Ignite Creation Date: 2025-12-24 @ 7:47 PM
Ignite Modification Date: 2026-02-21 @ 9:06 PM
Study NCT ID: NCT01111903
Status: COMPLETED
Last Update Posted: 2016-03-17
First Post: 2010-04-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A 2 Stage Trial of Lenalidomide (REV) in Asymptomatic Ovarian Cancer Patients With Increasing CA 125 in Late Relapse
Sponsor: ARCAGY/ GINECO GROUP
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module